Browsing Over 49 ePosters
Category- Advanced NSCLC
Filtered By
- Advanced NSCLC
Sort By
132PD - Plasma concentrations of pemetrexed to predict clinical outcomes in patients with advanced NSCLC
Authors
- Sabine Visser (NL)
- Stijn Koolen (NL)
- Peter De Bruijn (NL)
- Ron Mathijssen (NL)
- Bruno Stricker (NL)
- Joachim G. Aerts (NL)
Presenter
- Sabine Visser (NL)
133PD - Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) for non-small cell lung cancer (NSCLC): A systematic review and meta-analysis
Authors
- Jacques Raphael (CA)
- Mark Vincent (CA)
- Gabriel Boldt (CA)
- Prakeshkumar Shah (CA)
- George Rodrigues (CA)
- Phillip Blanchette (CA)
Presenter
- Jacques Raphael (CA)
134PD - Primary PFS and safety analyses of a randomized phase III study of carboplatin + paclitaxel +/− bevacizumab, with or without atezolizumab in 1L non-squamous metastatic NSCLC (IMpower150)
Authors
- Martin Reck (DE)
- Mark A. Socinski (US)
- Federico Cappuzzo (IT)
- Francisco Orlandi (CL)
- Daniil Stroyakovskiy (RU)
- Naoyuki Nogami (JP)
- Delvys Rodríguez-Abreu (ES)
- Denis Moro-Sibilot (FR)
- Christian A. Thomas (US)
- Fabrice Barlesi (FR)
- Gene Finley (US)
- Claudia Kelsch (US)
- Anthony Lee (US)
- Shelley Coleman (US)
- Yijing Shen (US)
- Marcin Kowanetz (US)
- Ariel Lopez Chavez (US)
- Alan Sandler (US)
- Robert M. Jotte (US)
Presenter
- Martin Reck (DE)
137PD - Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC)
Authors
- Oscar Juan (ES)
- Juan A. Méndez (ES)
- Benjamín Domingo-Arrué (ES)
- David Lorente Estelles (ES)
- Corina Escoín (ES)
- Carmen Salvador Coloma (ES)
- Edwin Navarro (ES)
- MARCOS Melian Sosa (ES)
- Nuria Mancheño (ES)
- José Gomez Codina (ES)
Presenter
- Oscar Juan (ES)
138PD_PR - Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)
Authors
- Maurice Perol (FR)
- Solange Peters (CH)
- Nick Pavlakis (AU)
- Evgeny Levchenko (RU)
- Marco Platania (IT)
- Julio Oliveira (PT)
- Silvia Novello (IT)
- Tom Karagiannis (US)
- Ali Zeaiter (CH)
- Rafal Dziadziuszko (PL)
Presenter
- Maurice Perol (FR)
139PD - Patient-reported outcomes from FLAURA: Osimertinib versus standard of care (SoC) epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) in patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC)
Authors
- Natasha Leighl (CA)
- Nina Karaseva (RU)
- Kazuhiko Nakagawa (JP)
- Byoung-Chul Cho (KR)
- Jhanelle E. Gray (US)
- Tina Hovey (GB)
- Andrew Walding (GB)
- Anna Rydén (SE)
- Silvia Novello (IT)
Presenter
- Natasha Leighl (CA)
140PD - Complex epidermal growth factor receptor (EGFR) mutations and responses to tyrosine kinase inhibitors (TKIs) in advanced lung adenocarcinomas
Authors
- Bo Zhang (CN)
- Shuyuan Wang (CN)
- Jie Qian (CN)
- Wenjia Yang (CN)
- Fangfei Qian (CN)
- Jun Lu (CN)
- Yanwei Zhang (CN)
- RONG Qiao (CN)
- Baohui Han (CN)
Presenter
- Bo Zhang (CN)
141PD - A prospective study of molecular testing status in the EGFR mutation positive NSCLC patients with disease progression during EGFR TKI treatment (REMEDY study)
Authors
- Kuninobu Kanai (JP)
- Nobuyuki Yamamoto (JP)
- Naoyuki Nogami (JP)
- Shinji Atagi (JP)
- Hideo Saka (JP)
- Naoki Tashiro (JP)
- Takashi Seto (JP)
Presenter
- Kuninobu Kanai (JP)
142PD - Detection of EGFR mutations in cerebrospinal fluid of EGFR-mutant lung adenocarcinoma with brain metastases
Authors
- Liang Shi (CN)
- Zhe Liu (CN)
- Junfang Tang (CN)
- Hongbo Wu (CN)
- Lili Guo (CN)
- Mingzhi Li (CN)
- Li Tong (CN)
- Wei Wu (CN)
- Hong Tao (CN)
- Weihua Wu (CN)
Presenter
- Liang Shi (CN)
143PD - Competing central nervous system or systemic progression analysis for patients with EGFR mutation-positive NSCLC receiving afatinib in LUX-Lung 3, 6, and 7
Authors
- James Chih-Hsin Yang (TW)
- Yi-Long Wu (CN)
- Vera Hirsh (CA)
- Kenneth O’byrne (AU)
- Nobuyuki Yamamoto (JP)
- Sanjay Popat (GB)
- Akihiro Tamiya (JP)
- Angela Märten (DE)
- Martin Schuler (DE)
Presenter
- James Chih-Hsin Yang (TW)
144PD - Leptomeningeal metastases in EGFR-mutated non-small cell lung carcinoma: Management after tyrosine kinase inhibitors
Authors
- Ronan Flippot (FR)
- Edouard Auclin (FR)
- Pamela Biondani (IT)
- Emilie Le Rhun (FR)
- David Planchard (FR)
- Caroline Caramella (FR)
- Cécile Le Pechoux (FR)
- Ludovic Lacroix (FR)
- Laura Mezquita (FR)
- Benjamin Besse (FR)
Presenter
- Ronan Flippot (FR)
145P - Impact of next-generation sequencing on survival in lung cancer
Authors
- Smadar Geva (IL)
- Anna Belilovski Rozenblum (IL)
- Laila C. Roisman (IL)
- Maya Ilouze (IL)
- Elizabeth Dudnik (IL)
- Alona Zer (IL)
- Ofer Rotem (IL)
- Nir Peled (IL)
Presenter
- Smadar Geva (IL)